Products & Programs PharmacyMedicaidMarch 1, 2024

Quarterly pharmacy formulary change notice

Summary of change

The formulary changes listed in the table below were reviewed and approved at our third quarter Pharmacy and Therapeutics Committee meeting.

What this means to you

Effective February 15, 2024, the changes outlined below apply to all members of Anthem.

Don’t forget to read the footnotes at the bottom of the tables.

What is the impact of this change?

EFFECTIVE FOR ALL PATIENTS ON FEBRUARY 15, 2024

Therapeutic class

Drug

Revised status

Potential alternatives

ANTIRETROVIRALS AGENTS

DESCOVY 200/25MG TABLET

DESCOVY 120-15MG TABLET

NON-PREFERRED WITH STEP THERAPY

EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE

TABLETS

(GENERIC TRUVADA)

UM EDITS – EFFECTIVE FOR ALL MEMBERS NO LATER THAN FEBRUARY 15, 2024

No changes in Preferred/Non-Preferred status revision or addition to UM edit only

ANTIRETROVIRALS AGENTS

SUNLENCA 300MG TABLET

SUNLENCA INJECTION

ADD PA 

What actions do I need to take?

Please work with your Anthem patients to transition to formulary alternatives. If you determine preferred formulary alternatives are not clinically appropriate for specific patients, you must obtain prior authorization to continue coverage beyond the applicable effective dates.

What if I need assistance?

We recognize the unique aspects of patients’ cases. If for medical reasons your Anthem patient cannot be converted to a formulary alternative, call Provider Services at 800-450-8753 and follow the voice prompts for pharmacy prior authorization. You can find the preferred drug list on our provider website at https://providers.anthem.com/ny.

If you need assistance with any other item, contact your local provider relationship management representative or call Provider Services at 800-450-8753.

Medicaid services provided by Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC.
Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NYBCBS-CD-049056-24

PUBLICATIONS: March 2024 Provider Newsletter